Impact of adding oxaliplatin to fluoropyrimidines in the adjuvant colon cancer: Experience in Ramon y Cajal University Hospital.

Olga Martínez-Sáez,Arantzazu Martínez Barquín García,Maria Villamayor-Delgado,Cristina Saavedra Serrano,Elena Corral de la Fuente,Juan José Serrano Domingo,Roberto Martín Huertas,Pablo Reguera Puertas,Federico Longo,Vanessa Pachon,Mercedes Rodríguez-Garrote,Carmen Guillen,Alfredo Carrato,Reyes Ferreiro Monteagudo

Impact of adding oxaliplatin to fluoropyrimidines in the adjuvant colon cancer: Experience in Ramon y Cajal University Hospital.

2018

Olga Martínez-Sáez
Arantzazu Martínez Barquín García
Maria Villamayor-Delgado
Cristina Saavedra Serrano
Elena Corral de la Fuente
Juan José Serrano Domingo
Roberto Martín Huertas
Pablo Reguera Puertas
Federico Longo
Vanessa Pachon
Mercedes Rodríguez-Garrote
Carmen Guillen
Alfredo Carrato
Reyes Ferreiro Monteagudo

815Background: The addition of oxaliplatin to fluorouracil and leucovorin as adjuvant therapy for patients with stage II and III colon cancer (CC) has been analyzed in two large, randomized trials,...

Keywords:

Adjuvant
Pathology
Oxaliplatin
Colorectal cancer
Cancer research
Medicine
university hospital
stage ii
Oncology
Internal medicine
Fluorouracil
Randomized controlled trial
Adjuvant therapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations